InnoCare Pharma Limited
HKEX:9969.HK
6.83 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 738.537 | 625.404 | 1,043.033 | 1.364 | 1.247 | 1.617 | 0.102 |
| Cost of Revenue
| 128.435 | 143.397 | 65.667 | 0 | 0 | 0 | 0 |
| Gross Profit
| 610.102 | 482.007 | 977.366 | 1.364 | 1.247 | 1.617 | 0.102 |
| Gross Profit Ratio
| 0.826 | 0.771 | 0.937 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 751.176 | 639.139 | 721.584 | 402.771 | 213.123 | 149.726 | 62.882 |
| General & Administrative Expenses
| 48.573 | 50.999 | 46.197 | 44.941 | 32.665 | 5.806 | 4.244 |
| Selling & Marketing Expenses
| 203.553 | 438.611 | 298.463 | 68.208 | 3.458 | 0.558 | 0 |
| SG&A
| 252.126 | 489.61 | 344.66 | 113.149 | 36.123 | 6.364 | 4.244 |
| Other Expenses
| -146.295 | 84.398 | 74.753 | -20.009 | 2.629 | -415.783 | -272.686 |
| Operating Expenses
| 1,259.815 | 1,213.147 | 1,140.997 | 495.911 | 251.875 | 150.264 | 67.123 |
| Operating Income
| -708.137 | -891.625 | -24.25 | -464.89 | -2,153.185 | -148.647 | -67.021 |
| Operating Income Ratio
| -0.959 | -1.426 | -0.023 | -340.828 | -1,726.692 | -91.928 | -657.069 |
| Total Other Income Expenses Net
| 63.932 | -2.102 | 4.129 | 0.627 | 2.834 | -405.376 | -274.713 |
| Income Before Tax
| -644.206 | -893.727 | -20.121 | -464.263 | -2,150.351 | -554.023 | -341.734 |
| Income Before Tax Ratio
| -0.872 | -1.429 | -0.019 | -340.369 | -1,724.419 | -342.624 | -3,350.333 |
| Income Tax Expense
| 1.426 | -22.077 | 46.558 | -1.097 | -11.797 | -403.929 | -273.117 |
| Net Income
| -631.263 | -871.65 | -66.679 | -463.166 | -2,138.554 | -549.95 | -341.734 |
| Net Income Ratio
| -0.855 | -1.394 | -0.064 | -339.565 | -1,714.959 | -340.105 | -3,350.333 |
| EPS
| -0.37 | -0.59 | -0.049 | -0.48 | -1.71 | -0.44 | -0.27 |
| EPS Diluted
| -0.37 | -0.59 | -0.049 | -0.48 | -1.71 | -0.44 | -0.27 |
| EBITDA
| -505.52 | -823.222 | 8.232 | -453.439 | -2,144.119 | -548.525 | -336.42 |
| EBITDA Ratio
| -0.684 | -1.316 | 0.008 | -332.433 | -1,719.422 | -339.224 | -3,298.235 |